Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€16.10
07.05.22
€20.00
07.05.23
222.26%
08.05.23

Could be very worthwhile Investment >20% year
melinda 
07.05.22 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.50
03.01.23
€30.00
31.12.25
76.00%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
03.01.23 70%
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.97
06.02.23
€27.00
31.12.25
87.64%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
06.02.23 50%
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€3.98
09.01.23
€8.00
31.12.25
178.89%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
09.01.23 60%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€6.10
19.12.22
€18.00
31.12.24
226.15%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
19.12.22 70%
buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€66.50
30.09.22
€120.00
31.12.24
324.36%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
30.09.22 50%
buy
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€47.20
07.02.23
€50.00
07.02.25
100.21%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
07.02.23 70%
buy
IVERIC bio Inc.

Start price
Target price
Perf. (%)
€17.23
29.09.22
€26.00
31.12.24
98.47%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
29.09.22 60%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€233.45
25.04.22
€250.00
25.04.23
14.61%
26.04.23

Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
tbackenh 
25.04.22 50%
sell
Merck KGaA

Start price
Target price
Perf. (%)
€190.20
23.01.23
€175.00
23.04.23
-12.41%
23.04.23

Some uniques
Future proof or reliable business model
overvalued
Low dividend yield expected
Snowman 
23.01.23 50%
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€152.08
07.09.22
€180.00
31.12.24
21.00%
21.03.23

Could be very worthwhile Investment >20% year
BiotechBee 
07.09.22 60%
buy
Meridian Bioscience Inc.

Start price
Target price
Perf. (%)
€19.00
28.01.22
€20.00
28.01.23
62.63%
29.01.23

Could be worthwhile Investment >10% per year
melinda 
28.01.22 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€407.05
24.01.22
€418.00
24.01.23
10.66%
25.01.23

Could be worthwhile Investment >10% per year
melinda 
24.01.22 50%
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€32.60
28.12.22
€40.00
28.12.23
50.15%
02.01.23

me8 
28.12.22 0%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€208.25
27.12.21
€215.00
27.12.22
23.82%
28.12.22

Could be worthwhile Investment >10% per year
melinda 
27.12.21 50%
buy
Horizon Pharma plc

Start price
Target price
Perf. (%)
€61.22
07.09.22
€100.00
31.12.25
73.41%
14.12.22

Could be very worthwhile Investment >20% year
BiotechBee 
07.09.22 70%
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€8.61
08.12.21
€10.00
08.12.22
65.85%
09.12.22

Could be worthwhile Investment >10% per year
melinda 
08.12.21 50%
buy
Chemed Corp.

Start price
Target price
Perf. (%)
€426.00
07.12.21
€445.00
07.12.22
14.08%
08.12.22

Could be worthwhile Investment >10% per year
melinda 
07.12.21 50%
buy
Oncopeptides AB

Start price
Target price
Perf. (%)
€1.02
02.12.21
€1.50
02.12.22
56.67%
03.12.22

Could be worthwhile Investment >10% per year
melinda 
02.12.21 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€140.70
27.11.21
€160.00
27.11.22
21.35%
28.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
MoneyMoney 
27.11.21 0%
buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€50.60
27.11.21
€60.00
27.11.22
26.48%
28.11.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
MoneyMoney 
27.11.21 0%
buy
Mediclin AG

Start price
Target price
Perf. (%)
€3.32
13.11.22
€3.00
13.11.23
-0.60%
26.11.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
kostojunior 
13.11.22 80%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€533.60
09.11.21
€600.00
09.11.22
38.91%
10.11.22

Could be worthwhile Investment >10% per year
melinda 
09.11.21 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.40
01.11.21
€15.00
01.11.22
79.03%
02.11.22

Could be worthwhile Investment >10% per year
melinda 
01.11.21 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.87
15.05.22
€68.00
15.05.23
32.12%
28.10.22

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
RudolfL 
15.05.22 50%